+1 347 708 0418
Oral Antidiabetic (OAD) Treatment market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Oral Antidiabetic (OAD) Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Sulphonylureas
Biguanides
Intestinal ?-Glucosidase Inhibitors
Others
Segment by Application
Hospital
Clinics
Diabetics Treatment Centres
Others
By Company
Pfizer
Eli Lilly
Merck
Sanofi
AstraZeneca
Glenmark
Novartis
Boehringer Ingelheim
Novo Nordisk
Mannkind
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oral Antidiabetic (OAD) Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Sulphonylureas
1.2.3 Biguanides
1.2.4 Intestinal ?-Glucosidase Inhibitors
1.2.5 Others
1.3 Market by Application
1.3.1 Global Oral Antidiabetic (OAD) Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Diabetics Treatment Centres
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Oral Antidiabetic (OAD) Treatment Market Perspective (2017-2028)
2.2 Oral Antidiabetic (OAD) Treatment Growth Trends by Region
2.2.1 Oral Antidiabetic (OAD) Treatment Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Oral Antidiabetic (OAD) Treatment Historic Market Size by Region (2017-2022)
2.2.3 Oral Antidiabetic (OAD) Treatment Forecasted Market Size by Region (2023-2028)
2.3 Oral Antidiabetic (OAD) Treatment Market Dynamics
2.3.1 Oral Antidiabetic (OAD) Treatment Industry Trends
2.3.2 Oral Antidiabetic (OAD) Treatment Market Drivers
2.3.3 Oral Antidiabetic (OAD) Treatment Market Challenges
2.3.4 Oral Antidiabetic (OAD) Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oral Antidiabetic (OAD) Treatment Players by Revenue
3.1.1 Global Top Oral Antidiabetic (OAD) Treatment Players by Revenue (2017-2022)
3.1.2 Global Oral Antidiabetic (OAD) Treatment Revenue Market Share by Players (2017-2022)
3.2 Global Oral Antidiabetic (OAD) Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Oral Antidiabetic (OAD) Treatment Revenue
3.4 Global Oral Antidiabetic (OAD) Treatment Market Concentration Ratio
3.4.1 Global Oral Antidiabetic (OAD) Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oral Antidiabetic (OAD) Treatment Revenue in 2021
3.5 Oral Antidiabetic (OAD) Treatment Key Players Head office and Area Served
3.6 Key Players Oral Antidiabetic (OAD) Treatment Product Solution and Service
3.7 Date of Enter into Oral Antidiabetic (OAD) Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Oral Antidiabetic (OAD) Treatment Breakdown Data by Type
4.1 Global Oral Antidiabetic (OAD) Treatment Historic Market Size by Type (2017-2022)
4.2 Global Oral Antidiabetic (OAD) Treatment Forecasted Market Size by Type (2023-2028)
5 Oral Antidiabetic (OAD) Treatment Breakdown Data by Application
5.1 Global Oral Antidiabetic (OAD) Treatment Historic Market Size by Application (2017-2022)
5.2 Global Oral Antidiabetic (OAD) Treatment Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Oral Antidiabetic (OAD) Treatment Market Size (2017-2028)
6.2 North America Oral Antidiabetic (OAD) Treatment Market Size by Type
6.2.1 North America Oral Antidiabetic (OAD) Treatment Market Size by Type (2017-2022)
6.2.2 North America Oral Antidiabetic (OAD) Treatment Market Size by Type (2023-2028)
6.2.3 North America Oral Antidiabetic (OAD) Treatment Market Share by Type (2017-2028)
6.3 North America Oral Antidiabetic (OAD) Treatment Market Size by Application
6.3.1 North America Oral Antidiabetic (OAD) Treatment Market Size by Application (2017-2022)
6.3.2 North America Oral Antidiabetic (OAD) Treatment Market Size by Application (2023-2028)
6.3.3 North America Oral Antidiabetic (OAD) Treatment Market Share by Application (2017-2028)
6.4 North America Oral Antidiabetic (OAD) Treatment Market Size by Country
6.4.1 North America Oral Antidiabetic (OAD) Treatment Market Size by Country (2017-2022)
6.4.2 North America Oral Antidiabetic (OAD) Treatment Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Oral Antidiabetic (OAD) Treatment Market Size (2017-2028)
7.2 Europe Oral Antidiabetic (OAD) Treatment Market Size by Type
7.2.1 Europe Oral Antidiabetic (OAD) Treatment Market Size by Type (2017-2022)
7.2.2 Europe Oral Antidiabetic (OAD) Treatment Market Size by Type (2023-2028)
7.2.3 Europe Oral Antidiabetic (OAD) Treatment Market Share by Type (2017-2028)
7.3 Europe Oral Antidiabetic (OAD) Treatment Market Size by Application
7.3.1 Europe Oral Antidiabetic (OAD) Treatment Market Size by Application (2017-2022)
7.3.2 Europe Oral Antidiabetic (OAD) Treatment Market Size by Application (2023-2028)
7.3.3 Europe Oral Antidiabetic (OAD) Treatment Market Share by Application (2017-2028)
7.4 Europe Oral Antidiabetic (OAD) Treatment Market Size by Country
7.4.1 Europe Oral Antidiabetic (OAD) Treatment Market Size by Country (2017-2022)
7.4.2 Europe Oral Antidiabetic (OAD) Treatment Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oral Antidiabetic (OAD) Treatment Market Size (2017-2028)
8.2 Asia-Pacific Oral Antidiabetic (OAD) Treatment Market Size by Type
8.2.1 Asia-Pacific Oral Antidiabetic (OAD) Treatment Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Oral Antidiabetic (OAD) Treatment Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Oral Antidiabetic (OAD) Treatment Market Share by Type (2017-2028)
8.3 Asia-Pacific Oral Antidiabetic (OAD) Treatment Market Size by Application
8.3.1 Asia-Pacific Oral Antidiabetic (OAD) Treatment Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Oral Antidiabetic (OAD) Treatment Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Oral Antidiabetic (OAD) Treatment Market Share by Application (2017-2028)
8.4 Asia-Pacific Oral Antidiabetic (OAD) Treatment Market Size by Region
8.4.1 Asia-Pacific Oral Antidiabetic (OAD) Treatment Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Oral Antidiabetic (OAD) Treatment Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Oral Antidiabetic (OAD) Treatment Market Size (2017-2028)
9.2 Latin America Oral Antidiabetic (OAD) Treatment Market Size by Type
9.2.1 Latin America Oral Antidiabetic (OAD) Treatment Market Size by Type (2017-2022)
9.2.2 Latin America Oral Antidiabetic (OAD) Treatment Market Size by Type (2023-2028)
9.2.3 Latin America Oral Antidiabetic (OAD) Treatment Market Share by Type (2017-2028)
9.3 Latin America Oral Antidiabetic (OAD) Treatment Market Size by Application
9.3.1 Latin America Oral Antidiabetic (OAD) Treatment Market Size by Application (2017-2022)
9.3.2 Latin America Oral Antidiabetic (OAD) Treatment Market Size by Application (2023-2028)
9.3.3 Latin America Oral Antidiabetic (OAD) Treatment Market Share by Application (2017-2028)
9.4 Latin America Oral Antidiabetic (OAD) Treatment Market Size by Country
9.4.1 Latin America Oral Antidiabetic (OAD) Treatment Market Size by Country (2017-2022)
9.4.2 Latin America Oral Antidiabetic (OAD) Treatment Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oral Antidiabetic (OAD) Treatment Market Size (2017-2028)
10.2 Middle East & Africa Oral Antidiabetic (OAD) Treatment Market Size by Type
10.2.1 Middle East & Africa Oral Antidiabetic (OAD) Treatment Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Oral Antidiabetic (OAD) Treatment Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Oral Antidiabetic (OAD) Treatment Market Share by Type (2017-2028)
10.3 Middle East & Africa Oral Antidiabetic (OAD) Treatment Market Size by Application
10.3.1 Middle East & Africa Oral Antidiabetic (OAD) Treatment Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Oral Antidiabetic (OAD) Treatment Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Oral Antidiabetic (OAD) Treatment Market Share by Application (2017-2028)
10.4 Middle East & Africa Oral Antidiabetic (OAD) Treatment Market Size by Country
10.4.1 Middle East & Africa Oral Antidiabetic (OAD) Treatment Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Oral Antidiabetic (OAD) Treatment Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Oral Antidiabetic (OAD) Treatment Introduction
11.1.4 Pfizer Revenue in Oral Antidiabetic (OAD) Treatment Business (2017-2022)
11.1.5 Pfizer Recent Developments
11.2 Eli Lilly
11.2.1 Eli Lilly Company Details
11.2.2 Eli Lilly Business Overview
11.2.3 Eli Lilly Oral Antidiabetic (OAD) Treatment Introduction
11.2.4 Eli Lilly Revenue in Oral Antidiabetic (OAD) Treatment Business (2017-2022)
11.2.5 Eli Lilly Recent Developments
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Merck Business Overview
11.3.3 Merck Oral Antidiabetic (OAD) Treatment Introduction
11.3.4 Merck Revenue in Oral Antidiabetic (OAD) Treatment Business (2017-2022)
11.3.5 Merck Recent Developments
11.4 Sanofi
11.4.1 Sanofi Company Details
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Oral Antidiabetic (OAD) Treatment Introduction
11.4.4 Sanofi Revenue in Oral Antidiabetic (OAD) Treatment Business (2017-2022)
11.4.5 Sanofi Recent Developments
11.5 AstraZeneca
11.5.1 AstraZeneca Company Details
11.5.2 AstraZeneca Business Overview
11.5.3 AstraZeneca Oral Antidiabetic (OAD) Treatment Introduction
11.5.4 AstraZeneca Revenue in Oral Antidiabetic (OAD) Treatment Business (2017-2022)
11.5.5 AstraZeneca Recent Developments
11.6 Glenmark
11.6.1 Glenmark Company Details
11.6.2 Glenmark Business Overview
11.6.3 Glenmark Oral Antidiabetic (OAD) Treatment Introduction
11.6.4 Glenmark Revenue in Oral Antidiabetic (OAD) Treatment Business (2017-2022)
11.6.5 Glenmark Recent Developments
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Novartis Business Overview
11.7.3 Novartis Oral Antidiabetic (OAD) Treatment Introduction
11.7.4 Novartis Revenue in Oral Antidiabetic (OAD) Treatment Business (2017-2022)
11.7.5 Novartis Recent Developments
11.8 Boehringer Ingelheim
11.8.1 Boehringer Ingelheim Company Details
11.8.2 Boehringer Ingelheim Business Overview
11.8.3 Boehringer Ingelheim Oral Antidiabetic (OAD) Treatment Introduction
11.8.4 Boehringer Ingelheim Revenue in Oral Antidiabetic (OAD) Treatment Business (2017-2022)
11.8.5 Boehringer Ingelheim Recent Developments
11.9 Novo Nordisk
11.9.1 Novo Nordisk Company Details
11.9.2 Novo Nordisk Business Overview
11.9.3 Novo Nordisk Oral Antidiabetic (OAD) Treatment Introduction
11.9.4 Novo Nordisk Revenue in Oral Antidiabetic (OAD) Treatment Business (2017-2022)
11.9.5 Novo Nordisk Recent Developments
11.10 Mannkind
11.10.1 Mannkind Company Details
11.10.2 Mannkind Business Overview
11.10.3 Mannkind Oral Antidiabetic (OAD) Treatment Introduction
11.10.4 Mannkind Revenue in Oral Antidiabetic (OAD) Treatment Business (2017-2022)
11.10.5 Mannkind Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Oral Antidiabetic (OAD) Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Sulphonylureas
Table 3. Key Players of Biguanides
Table 4. Key Players of Intestinal ?-Glucosidase Inhibitors
Table 5. Key Players of Others
Table 6. Global Oral Antidiabetic (OAD) Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 7. Global Oral Antidiabetic (OAD) Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Oral Antidiabetic (OAD) Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Oral Antidiabetic (OAD) Treatment Market Share by Region (2017-2022)
Table 10. Global Oral Antidiabetic (OAD) Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Oral Antidiabetic (OAD) Treatment Market Share by Region (2023-2028)
Table 12. Oral Antidiabetic (OAD) Treatment Market Trends
Table 13. Oral Antidiabetic (OAD) Treatment Market Drivers
Table 14. Oral Antidiabetic (OAD) Treatment Market Challenges
Table 15. Oral Antidiabetic (OAD) Treatment Market Restraints
Table 16. Global Oral Antidiabetic (OAD) Treatment Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Oral Antidiabetic (OAD) Treatment Revenue Share by Players (2017-2022)
Table 18. Global Top Oral Antidiabetic (OAD) Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Antidiabetic (OAD) Treatment as of 2021)
Table 19. Ranking of Global Top Oral Antidiabetic (OAD) Treatment Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Oral Antidiabetic (OAD) Treatment Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Oral Antidiabetic (OAD) Treatment Product Solution and Service
Table 23. Date of Enter into Oral Antidiabetic (OAD) Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Oral Antidiabetic (OAD) Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Oral Antidiabetic (OAD) Treatment Revenue Market Share by Type (2017-2022)
Table 27. Global Oral Antidiabetic (OAD) Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Oral Antidiabetic (OAD) Treatment Revenue Market Share by Type (2023-2028)
Table 29. Global Oral Antidiabetic (OAD) Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Oral Antidiabetic (OAD) Treatment Revenue Share by Application (2017-2022)
Table 31. Global Oral Antidiabetic (OAD) Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Oral Antidiabetic (OAD) Treatment Revenue Share by Application (2023-2028)
Table 33. North America Oral Antidiabetic (OAD) Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 34. North America Oral Antidiabetic (OAD) Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 35. North America Oral Antidiabetic (OAD) Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 36. North America Oral Antidiabetic (OAD) Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 37. North America Oral Antidiabetic (OAD) Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 38. North America Oral Antidiabetic (OAD) Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 39. Europe Oral Antidiabetic (OAD) Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 40. Europe Oral Antidiabetic (OAD) Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 41. Europe Oral Antidiabetic (OAD) Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 42. Europe Oral Antidiabetic (OAD) Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 43. Europe Oral Antidiabetic (OAD) Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 44. Europe Oral Antidiabetic (OAD) Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 45. Asia Pacific Oral Antidiabetic (OAD) Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 46. Asia Pacific Oral Antidiabetic (OAD) Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 47. Asia Pacific Oral Antidiabetic (OAD) Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 48. Asia Pacific Oral Antidiabetic (OAD) Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 49. Asia Pacific Oral Antidiabetic (OAD) Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 50. Asia Pacific Oral Antidiabetic (OAD) Treatment Market Size by Region (2023-2028) & (US$ Million)
Table 51. Latin America Oral Antidiabetic (OAD) Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 52. Latin America Oral Antidiabetic (OAD) Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 53. Latin America Oral Antidiabetic (OAD) Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 54. Latin America Oral Antidiabetic (OAD) Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 55. Latin America Oral Antidiabetic (OAD) Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 56. Latin America Oral Antidiabetic (OAD) Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Oral Antidiabetic (OAD) Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Oral Antidiabetic (OAD) Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Oral Antidiabetic (OAD) Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Oral Antidiabetic (OAD) Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Oral Antidiabetic (OAD) Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Oral Antidiabetic (OAD) Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 63. Pfizer Company Details
Table 64. Pfizer Business Overview
Table 65. Pfizer Oral Antidiabetic (OAD) Treatment Product
Table 66. Pfizer Revenue in Oral Antidiabetic (OAD) Treatment Business (2017-2022) & (US$ Million)
Table 67. Pfizer Recent Developments
Table 68. Eli Lilly Company Details
Table 69. Eli Lilly Business Overview
Table 70. Eli Lilly Oral Antidiabetic (OAD) Treatment Product
Table 71. Eli Lilly Revenue in Oral Antidiabetic (OAD) Treatment Business (2017-2022) & (US$ Million)
Table 72. Eli Lilly Recent Developments
Table 73. Merck Company Details
Table 74. Merck Business Overview
Table 75. Merck Oral Antidiabetic (OAD) Treatment Product
Table 76. Merck Revenue in Oral Antidiabetic (OAD) Treatment Business (2017-2022) & (US$ Million)
Table 77. Merck Recent Developments
Table 78. Sanofi Company Details
Table 79. Sanofi Business Overview
Table 80. Sanofi Oral Antidiabetic (OAD) Treatment Product
Table 81. Sanofi Revenue in Oral Antidiabetic (OAD) Treatment Business (2017-2022) & (US$ Million)
Table 82. Sanofi Recent Developments
Table 83. AstraZeneca Company Details
Table 84. AstraZeneca Business Overview
Table 85. AstraZeneca Oral Antidiabetic (OAD) Treatment Product
Table 86. AstraZeneca Revenue in Oral Antidiabetic (OAD) Treatment Business (2017-2022) & (US$ Million)
Table 87. AstraZeneca Recent Developments
Table 88. Glenmark Company Details
Table 89. Glenmark Business Overview
Table 90. Glenmark Oral Antidiabetic (OAD) Treatment Product
Table 91. Glenmark Revenue in Oral Antidiabetic (OAD) Treatment Business (2017-2022) & (US$ Million)
Table 92. Glenmark Recent Developments
Table 93. Novartis Company Details
Table 94. Novartis Business Overview
Table 95. Novartis Oral Antidiabetic (OAD) Treatment Product
Table 96. Novartis Revenue in Oral Antidiabetic (OAD) Treatment Business (2017-2022) & (US$ Million)
Table 97. Novartis Recent Developments
Table 98. Boehringer Ingelheim Company Details
Table 99. Boehringer Ingelheim Business Overview
Table 100. Boehringer Ingelheim Oral Antidiabetic (OAD) Treatment Product
Table 101. Boehringer Ingelheim Revenue in Oral Antidiabetic (OAD) Treatment Business (2017-2022) & (US$ Million)
Table 102. Boehringer Ingelheim Recent Developments
Table 103. Novo Nordisk Company Details
Table 104. Novo Nordisk Business Overview
Table 105. Novo Nordisk Oral Antidiabetic (OAD) Treatment Product
Table 106. Novo Nordisk Revenue in Oral Antidiabetic (OAD) Treatment Business (2017-2022) & (US$ Million)
Table 107. Novo Nordisk Recent Developments
Table 108. Mannkind Company Details
Table 109. Mannkind Business Overview
Table 110. Mannkind Oral Antidiabetic (OAD) Treatment Product
Table 111. Mannkind Revenue in Oral Antidiabetic (OAD) Treatment Business (2017-2022) & (US$ Million)
Table 112. Mannkind Recent Developments
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Oral Antidiabetic (OAD) Treatment Market Share by Type: 2021 VS 2028
Figure 2. Sulphonylureas Features
Figure 3. Biguanides Features
Figure 4. Intestinal ?-Glucosidase Inhibitors Features
Figure 5. Others Features
Figure 6. Global Oral Antidiabetic (OAD) Treatment Market Share by Application: 2021 VS 2028
Figure 7. Hospital Case Studies
Figure 8. Clinics Case Studies
Figure 9. Diabetics Treatment Centres Case Studies
Figure 10. Others Case Studies
Figure 11. Oral Antidiabetic (OAD) Treatment Report Years Considered
Figure 12. Global Oral Antidiabetic (OAD) Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 13. Global Oral Antidiabetic (OAD) Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Oral Antidiabetic (OAD) Treatment Market Share by Region: 2021 VS 2028
Figure 15. Global Oral Antidiabetic (OAD) Treatment Market Share by Players in 2021
Figure 16. Global Top Oral Antidiabetic (OAD) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Antidiabetic (OAD) Treatment as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Oral Antidiabetic (OAD) Treatment Revenue in 2021
Figure 18. North America Oral Antidiabetic (OAD) Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 19. North America Oral Antidiabetic (OAD) Treatment Market Size Market Share by Type (2017-2028)
Figure 20. North America Oral Antidiabetic (OAD) Treatment Market Size Market Share by Application (2017-2028)
Figure 21. North America Oral Antidiabetic (OAD) Treatment Market Size Share by Country (2017-2028)
Figure 22. United States Oral Antidiabetic (OAD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Canada Oral Antidiabetic (OAD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe Oral Antidiabetic (OAD) Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 25. Europe Oral Antidiabetic (OAD) Treatment Market Size Market Share by Type (2017-2028)
Figure 26. Europe Oral Antidiabetic (OAD) Treatment Market Size Market Share by Application (2017-2028)
Figure 27. Europe Oral Antidiabetic (OAD) Treatment Market Size Share by Country (2017-2028)
Figure 28. Germany Oral Antidiabetic (OAD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. France Oral Antidiabetic (OAD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. U.K. Oral Antidiabetic (OAD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Italy Oral Antidiabetic (OAD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Russia Oral Antidiabetic (OAD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Nordic Countries Oral Antidiabetic (OAD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Asia-Pacific Oral Antidiabetic (OAD) Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 35. Asia Pacific Oral Antidiabetic (OAD) Treatment Market Size Market Share by Type (2017-2028)
Figure 36. Asia Pacific Oral Antidiabetic (OAD) Treatment Market Size Market Share by Application (2017-2028)
Figure 37. Asia Pacific Oral Antidiabetic (OAD) Treatment Market Size Share by Region (2017-2028)
Figure 38. China Oral Antidiabetic (OAD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Japan Oral Antidiabetic (OAD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. South Korea Oral Antidiabetic (OAD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Southeast Asia Oral Antidiabetic (OAD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. India Oral Antidiabetic (OAD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Australia Oral Antidiabetic (OAD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 44. Latin America Oral Antidiabetic (OAD) Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 45. Latin America Oral Antidiabetic (OAD) Treatment Market Size Market Share by Type (2017-2028)
Figure 46. Latin America Oral Antidiabetic (OAD) Treatment Market Size Market Share by Application (2017-2028)
Figure 47. Latin America Oral Antidiabetic (OAD) Treatment Market Size Share by Country (2017-2028)
Figure 48. Mexico Oral Antidiabetic (OAD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Brazil Oral Antidiabetic (OAD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Middle East & Africa Oral Antidiabetic (OAD) Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 51. Middle East and Africa Oral Antidiabetic (OAD) Treatment Market Size Market Share by Type (2017-2028)
Figure 52. Middle East and Africa Oral Antidiabetic (OAD) Treatment Market Size Market Share by Application (2017-2028)
Figure 53. Middle East and Africa Oral Antidiabetic (OAD) Treatment Market Size Share by Country (2017-2028)
Figure 54. Turkey Oral Antidiabetic (OAD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Saudi Arabia Oral Antidiabetic (OAD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. UAE Oral Antidiabetic (OAD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. Pfizer Revenue Growth Rate in Oral Antidiabetic (OAD) Treatment Business (2017-2022)
Figure 58. Eli Lilly Revenue Growth Rate in Oral Antidiabetic (OAD) Treatment Business (2017-2022)
Figure 59. Merck Revenue Growth Rate in Oral Antidiabetic (OAD) Treatment Business (2017-2022)
Figure 60. Sanofi Revenue Growth Rate in Oral Antidiabetic (OAD) Treatment Business (2017-2022)
Figure 61. AstraZeneca Revenue Growth Rate in Oral Antidiabetic (OAD) Treatment Business (2017-2022)
Figure 62. Glenmark Revenue Growth Rate in Oral Antidiabetic (OAD) Treatment Business (2017-2022)
Figure 63. Novartis Revenue Growth Rate in Oral Antidiabetic (OAD) Treatment Business (2017-2022)
Figure 64. Boehringer Ingelheim Revenue Growth Rate in Oral Antidiabetic (OAD) Treatment Business (2017-2022)
Figure 65. Novo Nordisk Revenue Growth Rate in Oral Antidiabetic (OAD) Treatment Business (2017-2022)
Figure 66. Mannkind Revenue Growth Rate in Oral Antidiabetic (OAD) Treatment Business (2017-2022)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Buy
